UK markets close in 7 hours 6 minutes

Pieris Pharmaceuticals, Inc. (PIRS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
10.99-0.06 (-0.58%)
At close: 04:00PM EDT
10.91 -0.08 (-0.69%)
After hours: 07:46PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
47,357
-
25,902
31,418
29,323
46,279
Operating expenses
Research development
50,727
-
52,982
66,656
46,531
54,996
Selling general and administrative
18,511
-
16,394
16,593
16,713
18,440
Total operating expenses
62,235
-
61,203
79,564
63,244
73,436
Operating income or loss
-14,878
-
-35,301
-48,146
-33,921
-27,157
Total other income/expenses net
-14,930
-
1,303
2,404
-3,656
-26
Income before tax
-28,061
-
-33,277
-45,738
-37,066
-25,469
Income tax expense
-
-
-
0
164
0
Income from continuing operations
-28,061
-
-33,277
-45,738
-37,230
-25,469
Net income
-28,061
-
-33,277
-45,738
-37,230
-25,469
Net income available to common shareholders
-28,061
-
-33,277
-45,738
-37,230
-28,299
Basic EPS
-0.34
-21.60
-36.00
-56.80
-54.40
-
Diluted EPS
-0.34
-21.60
-36.00
-56.80
-54.40
-
Basic average shares
83,932
1,126
927.15
806.837
681.012
-
Diluted average shares
83,932
1,126
927.15
806.837
681.012
-